Antineoplastics and immunomodulators 2026-II Imunosupresivums content as an active substance
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Antineoplastics and immunomodulators 2026-II Imunosupresivums content as an active substance
P.o. form s content 30 mg of preparation for each form, pre-packaged annual volume 5 600 units of form (dávek); ATC L04AA32
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals